aloisines (CNRS)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namealoisines (CNRS)
Drug Alias Namepyrrolo-pyrazine derivatives (CNRS)cyclin-dependent kinase 2/glycogen synthase kinase 3 inhibitors (CNRS)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 inhibitorsCyclin-dependent kinase 2 inhibitors
TargetsGlycogen synthase kinase-3Cyclin-dependent kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCNRS InnovationCentre National De La Recherche Scientifique (Cnrs)
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A